Repligen
RGEN
#2530
Rank
A$10.02 B
Marketcap
A$177.67
Share price
2.47%
Change (1 day)
-12.06%
Change (1 year)
Categories

Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Volume in USD (price x number of shares), data since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$20.29 M-7.22%
2025A$21.87 M-36.33%
2024A$34.35 M-68.17%
2023A$0.10 B60.05%
2022A$67.43 M90.89%
2021A$35.32 M-76.42%
2020A$0.14 B197.63%
2019A$50.34 M-29.09%
2018A$70.99 M835.37%
2017A$7.59 M22.08%
2016A$6.21 M-19.68%
2015A$7.74 M-7.23%
2014A$8.34 M721.71%
2013A$1.01 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
A$62.76 MA$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$5.56 MA$56.61 M๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$49.94 MA$0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$9.51 MA$65.77 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$1.45 MA$7.81 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$13.82 MA$63.61 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$13.95 MA$26.48 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$34 MA$49.46 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.79 MA$16.56 M๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$12.14 MA$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA